NCT00275236View on ClinicalTrials.gov

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Restless Legs Syndrome
Interventions
DRUG

Rotigotine

Trial Locations (1)

Unknown

Schwarz BioSciences, Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY